Inhibition of spinal astrocytic c-Jun N-terminal kinase (JNK) activation correlates with the analgesic effects of ketamine in neuropathic pain
2011

Ketamine Reduces Pain by Inhibiting JNK Activation in Spinal Astrocytes

Sample size: 60 publication Evidence: moderate

Author Information

Author(s): Mei Xiao-Peng, Zhang Hui, Wang Wei, Wei Yan-Yan, Zhai Ming-Zhu, Wang Wen, Xu Li-Xian, Li Yun-Qing

Primary Institution: Fourth Military Medical University, Xi'an, PR China

Hypothesis

Inhibition of astrocytic JNK activation might be involved in the suppressive effect of ketamine on SNL-induced spinal astrocytic activation.

Conclusion

Inhibition of JNK activation may be involved in the analgesic effects of ketamine on SNL-induced neuropathic pain.

Supporting Evidence

  • SNL induced significant mechanical allodynia as shown by von-Frey tests.
  • Intrathecal ketamine (100 and 300 μg kg-1) showed an effective and reliable anti-allodynia effect in a dose-dependent manner.
  • Intrathecal ketamine significantly suppressed nerve injury-induced mechanical allodynia.
  • Ketamine inhibited pJNK expression in a dose-dependent manner.

Takeaway

Ketamine helps reduce pain by stopping certain brain cells from becoming too active after nerve injury.

Methodology

The study used immunofluorescence histochemistry and Western blot to measure pJNK expression and behavioral tests to assess pain response.

Participant Demographics

Male Sprague-Dawley rats, weighing 180-200 g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1742-2094-8-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication